Dr. Taraneh Mehrani

Mary Ellen Csuka, MD, FACP, Professor of Medicine in the Division of Rheumatology, graduated from the New York Medical College in 1977 and completed her residency in Internal Medicine at The Hartford Hospital in Hartford, Conn. In 1980, Dr. Csuka joined MCW as a general internist. In 1986, she became board-certified in rheumatology and joined the Division of Rheumatology. Dr. Csuka established the Froedtert MCW Scleroderma clinic, which is recognized by the Scleroderma Foundation as a Research and Treatment Center since 2013.She has a long-standing interest and commitment to the prevention and treatment of postmenopausal osteoporosis. Her medical expertise and training in rheumatology and geriatrics allow her to serve as a clinical resource for her colleagues at MCW and in the community. She has been a presenter at the Wisconsin Update in Geriatric Medicine since its inception. She has received numerous grants, awards and contracts and is an invited lecturer locally, nationally, and internationally. Dr. Csuka is highly rated in 10 conditions, according to our data. Her clinical expertise encompasses Systemic Sclerosis (SSc), Scleroderma, Scleroma, and Osteoporosis. Dr. Csuka is board certified in Geriatric Medicine, Internal Medicine, and Rheumatology. Dr. Csuka is currently accepting new patients.

Mike Putman, MD/MSci, is an associate professor of medicine at the Medical College of Wisconsin, where he serves as the associate fellowship program director and the medical director of the Vasculitis Program. He is also involved in medical education and is the co-director of the hematology/immunology block and the co-director of the Evidence Based Medicine Longitudinal Thread. From a research perspective, he conducts meta-research and studies giant cell arteritis on a Rheumatology Research Foundation Scientist Development Grant. In his spare time, he hosts the Evidence Based Rheumatology podcast and is an associate editor of the journal Rheumatology. Dr. Putman is highly rated in 8 conditions, according to our data. His clinical expertise encompasses Giant Cell Arteritis (GCA), Temporal Arteritis, Juvenile Temporal Arteritis, and Necrotizing Vasculitis. Dr. Putman is board certified in Internal Medicine and Rheumatology. Dr. Putman is currently accepting new patients.

Dr. Rosenthal is the Will and Cava Ross Professor of Medicine in the Division of Rheumatology at the Medical College of Wisconsin, and Chief of the Rheumatology Division. She the medical director of the Zablocki VA Translational Research Center, a key component of the Clinical Translational Science Institute and recently became the Associate Chief of Staff for Research at the VA Medical Center. She maintains an active clinical practice, has been elected a fellow in the American College of Physicians, and is the winner of several teaching awards.Dr. Rosenthal received her MD from Johns Hopkins University School of Medicine and completed residency in Internal Medicine at the University of Rochester. She received her rheumatology training at the Medical College of Wisconsin. Her principal research interests revolve around pathogenic mechanisms of a common form of arthritis known as calcium pyrophosphate deposition disease. This work has been funded by the Veteran’s Administration Research Service and the National Institutes of Health since 1991. Other research interests include osteoarthritis and gout as well as musculoskeletal complications of diabetes. She is the author of over 80 original publications, numerous chapters and invited reviews, and has spoken at many national and international meetings. She is an enthusiastic study section member for NIH and the VA and is an active mentor for the US Bone and Joint Decade Young Investigators Initiative. Dr. Rosenthal is highly rated in 6 conditions, according to our data. Her clinical expertise encompasses Calcium Pyrophosphate Arthritis, Chondrocalcinosis 2, Arthritis, and Gout. Dr. Rosenthal is board certified in Internal Medicine and Rheumatology.